WLKP — Westlake Chemical Partners LP stock price, charts and financials
QT56Westlake Chemical Partners LPWestlake Chemical Partners LP (NYSE: WLKP) is a Basic Materials company in the Chemicals industry. QuoTrend tracks its price, financials, earnings, analyst ratings and insider trades.
Latest market price
21.27
-0.37-1.71%
TA
Loading chart...
Snapshot
| Index | - | P/E | 5.98 | EPS (ttm) | 3.62 | Insider Own | - | Shs Outstand | 35.25M | Perf Week | -1.86% |
| Market Cap | 762.72M | Forward P/E | 12.65 | EPS next Y | 1.71 | Insider Trans | - | Shs Float | 19.44M | Perf Month | -2.92% |
| Enterprise Value | 1.12B | PEG | 0.04 | EPS next Q | - | Inst Own | 29.11% | Short Float | 0.75% | Perf Quarter | -6.12% |
| Income | 126.99M | P/S | 0.62 | EPS this Y | -48.07% | Inst Trans | - | Short Ratio | 5.51 | Perf Half Y | -0.18% |
| Sales | 1.23B | P/B | 1.54 | EPS next Y | -9.04% | ROA | 10.33% | Short Interest | 145.07K | Perf YTD | 13.89% |
| Book/sh | - | P/C | 2.22 | EPS next 5Y | 4.68% | ROE | 25.43% | 52W High | 23.47 -9.38% | Perf Year | -1.46% |
| Cash/sh | - | P/FCF | 2.76 | EPS past 3/5Y | 66.96% 35.13% | ROIC | 30.03% | 52W Low | 17.45 21.92% | Perf 3Y | -5.30% |
| Dividend Est. | 1.89 (8.87%) | EV/EBITDA | 2.40 | Sales past 3/5Y | -9.85% 3.83% | Gross Margin | 31.39% | Volatility | 2.28% 2.07% | Perf 5Y | -19.91% |
| Dividend TTM | 1.89 (8.87%) | EV/Sales | 0.91 | EPS Y/Y TTM | 104.52% | Oper. Margin | 29.12% | ATR (14) | 0.46 | Perf 10Y | -8.27% |
| Dividend Ex-Date | May 14, 2026 | Quick Ratio | 3.57 | Sales Y/Y TTM | 8.71% | Profit Margin | 10.34% | RSI (14) | 34.05 | Recom | 2.70 |
| Dividend Gr. 3/5Y | 0.00% 0.00% | Current Ratio | 3.65 | EPS Q/Q | 185.71% | SMA20 | -1.61% | Beta | 0.51 | Target Price | 29.00 |
| Payout | 52.07% | Debt/Eq | 0.80 | Sales Q/Q | 28.57% | SMA50 | -3.84% | Rel Volume | 1.73 | Prev Close | 21.64 |
| Employees | 2,169 | LT Debt/Eq | 0.50 | Earnings | Aug 04 | SMA200 | 1.74% | Avg Volume | 29.27K | Price | 21.27 |
| IPO Date | Jul 30, 2014 | Option/Short | Yes / Yes | EPS/Sales Surpr. | -6.98% -41.44% | Net Debt/EBITDA | 0.76 | Volume | 50,579 | Change | -1.71% |
Analyst Ratings
| Date | Action | Analyst | Rating | Target |
|---|---|---|---|---|
| Nov-18-22 | Reiterated | Deutsche Bank | Buy | $30 → $29 |
| May-16-22 | Reiterated | Deutsche Bank | Buy | $30 |
| Mar-18-21 | Downgrade | UBS | Buy → Neutral | |
| Aug-20-20 | Upgrade | Tudor Pickering | Sell → Hold | |
| Oct-09-19 | Downgrade | Citigroup | Buy → Neutral | |
| Oct-09-19 | Downgrade | Citi | Buy → Neutral | |
| Sep-13-19 | Upgrade | Barclays | Equal Weight → Overweight |
Latest News
Jul-21-26
Jul-21-2608:00AM
Jul-11-26
Company
Westlake Chemical Partners LP concentrates on acquiring, developing, and operating facilities dedicated to ethylene production, along with related infrastructure, throughout the United States. These plants primarily function by converting ethane into ethylene. Furthermore, the partnership distributes a range of chemical co-products—such as propylene, crude butadiene, pyrolysis gasoline, and hydrogen—directly to external buyers, conducting these sales through either immediate spot transactions or established contractual agreements. Westlake Chemical Partners GP LLC serves as the entity's general partner. The company was founded in 2014 and its corporate headquarters are located in Houston, Texas.
Ownership
Total institutional ownership29.11%
Per-holder 13F data hasn't been ingested for this ticker yet.
Financial Statements
DataTimeframe
| Line Item (USD, M) | TTM — | FY 2025 12/31/2025 | FY 2024 12/31/2024 | FY 2023 12/31/2023 | FY 2022 12/31/2022 | FY 2021 12/31/2021 | FY 2020 12/31/2020 | FY 2019 12/31/2019 | FY 2018 12/31/2018 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total Revenue | 1,235 | 1,167 | 1,136 | 1,191 | 1,593 | 1,215 | 967 | 1,092 | 1,286 | |
| Cost of Goods Sold Incl. D&A | 847 | 819 | 717 | 803 | 1,216 | 773 | 588 | 712 | 908 | |
| Gross Profit | 388 | 348 | 419 | 387 | 377 | 442 | 379 | 379 | 377 | |
| Selling, General and Administrative Excl. Other | 27 | 28 | 28 | 30 | 30 | 31 | 26 | 29 | 28 | |
| Research and Development | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |
| Other Operating Expense | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |
| Operating Income | 360 | 320 | 390 | 358 | 348 | 411 | 353 | 350 | 350 | |
| Interest Expense | 36 | 23 | 26 | 27 | 13 | 9 | 12 | 20 | 21 | |
| Unusual Expense | — | — | — | — | — | — | — | — | — | |
| Non-Operating Income (Expense) | 14 | 2 | 5 | 4 | 2 | 0 | 1 | 3 | 2 | |
| Net Income Before Taxes | 338 | 299 | 370 | 335 | 336 | 402 | 342 | 334 | 331 | |
| Income Taxes | 0 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 0 | |
| Consolidated Net Income | 128 | 299 | 62 | 54 | 64 | 83 | 66 | 61 | 49 | |
| Net Income From Continuing Operations | 338 | 299 | 369 | 335 | 335 | 401 | 341 | 333 | 331 | |
| Net Income | 128 | 299 | 62 | 54 | 64 | 83 | 66 | 61 | 49 | |
| EPS (Recurring) | 3.62 | 8.47 | 1.77 | 1.54 | 1.82 | 2.34 | 1.88 | 1.77 | 1.53 | |
| EPS (Basic, Before Extraordinaries) | 3.62 | 8.47 | 1.77 | 1.54 | 1.82 | 2.34 | 1.88 | 1.77 | 1.53 | |
| EPS (Diluted) | 3.62 | 8.47 | 1.77 | 1.54 | 1.82 | 2.34 | 1.88 | 1.77 | 1.51 | |
| EBITDA | 467 | 450 | 508 | 472 | 470 | 520 | 457 | 461 | 461 | |
| Other After Tax Adjustments | — | — | — | — | — | — | — | — | — | |
| Stock Option Compensation Expense | — | — | — | — | — | — | — | — | — | |
| Price To Earnings Ratio | 5.88 | 2.24 | 13.07 | 14.06 | 12.91 | 11.48 | 12.68 | 14.93 | 15.98 | |
| Price To Sales Ratio | 0.60 | 0.57 | 0.71 | 0.64 | 0.52 | 0.77 | 0.86 | 0.82 | 0.60 | |
| Gross Margin | 31.42 | 29.82 | 36.88 | 32.49 | 23.67 | 36.38 | 39.19 | 34.71 | 29.32 | |
| Operating Margin | 29.15 | 27.42 | 34.33 | 30.06 | 21.85 | 33.83 | 36.50 | 32.05 | 27.22 | |
| Net Margin | 10.36 | 25.62 | 5.46 | 4.53 | 4.02 | 6.83 | 6.83 | 5.59 | 3.81 | |
| Shares Outstanding | 35 | 35 | 35 | 35 | 35 | 35 | 35 | 34 | 32 | |
| Market Capitalization | 744 | 665 | 810 | 758 | 823 | 940 | 834 | 898 | 772 | |
| Operating Lease Expense | — | — | — | — | — | — | — | — | — |
Unlock full historical data
See years of past statements with Premium.
Insider Trading Volume
Insider Trading
| Insider | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total | SEC Form 4 |
|---|---|---|---|---|---|---|---|---|
| Gilson Jean-Marc | President and CEO | Aug 27 '25 | Buy | 21.25 | 95 | 2,025 | 11,803 | Aug 29 |
| Gilson Jean-Marc | President and CEO | Aug 21 '25 | Buy | 22.02 | 1,250 | 27,530 | 11,708 | Aug 28 |
| Gilson Jean-Marc | President and CEO | Aug 20 '25 | Buy | 21.86 | 1,250 | 27,329 | 10,458 | Aug 28 |
| Gilson Jean-Marc | President and CEO | Aug 15 '25 | Buy | 21.84 | 4,700 | 102,653 | 9,208 | Aug 28 |
| Gilson Jean-Marc | President and CEO | May 29 '25 | Buy | 22.20 | 94 | 2,081 | 4,508 | Aug 28 |
| Gilson Jean-Marc | President and CEO | Feb 25 '25 | Buy | 24.75 | 83 | 2,042 | 4,414 | Aug 28 |
| Gilson Jean-Marc | President and CEO | Nov 27 '24 | Buy | 23.57 | 85 | 2,002 | 4,332 | Aug 28 |
| Gilson Jean-Marc | President and CEO | Aug 28 '24 | Buy | 22.94 | 820 | 18,814 | 3,427 | Aug 28 |
| WOELFEL RANDY | Director | Aug 07 '25 | Option Exercise | 0.00 | 4,882 | 0 | 28,795 | Aug 08 |
| FINLEY G STEPHEN | Director | Aug 07 '25 | Option Exercise | 0.00 | 4,882 | 0 | 31,930 | Aug 08 |
| Friel Lisa A. | Director | Aug 07 '25 | Option Exercise | 0.00 | 4,882 | 0 | 9,604 | Aug 08 |
| Chao James | Senior Chairman | May 29 '25 | Sale | 22.10 | 3,700 | 81,770 | 0 | May 30 |
| Chao James | Senior Chairman | May 28 '25 | Sale | 22.10 | 4,600 | 101,660 | 3,700 | May 29 |
| Chao James | Senior Chairman | May 27 '25 | Sale | 22.17 | 5,608 | 124,329 | 8,300 | May 29 |
| Gilson Jean-Marc | President and CEO | Aug 29 '24 | Buy | 22.83 | 1,000 | 22,830 | 3,927 | Sep 03 |
QuoTrend signals describe historical patterns and statistics — educational information, not investment advice or a recommendation to buy or sell. Past performance doesn’t guarantee future results. Every figure traces to QuoTrend data. Historical patterns — not a prediction or advice.